MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Premier Interest Expense 2011-2025 | PINC
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Premier
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102 M | 20.8 M | 6.31 M | -9.65 M | 12 M | 4.15 M | -3.54 M | 3.34 M | 614 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 102 M | -9.65 M | 15.1 M |
Quarterly Interest Expense Premier
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.08 M | 12.2 M | 23.3 M | 60.3 M | 14.9 M | 4.68 M | -1.09 M | 2.95 M | 2.93 M | -2.16 M | 766 K | -4.25 M | 2.39 M | -320 K | 2.07 M | 1.59 M | 4.89 M | 3.68 M | 4.89 M | 3.68 M | 2.75 M | 262 K | 2.75 M | 3.67 M | -3.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 60.3 M | -4.25 M | 5.77 M |
Interest Expense of other stocks in the Health information services industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Covetrus
CVET
|
32 M | - | - | $ 2.94 B |  USA |
 |
Cerner Corporation
CERN
|
43.5 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
12.5 M | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
-147 K | - | 0.29 % | $ 206 M | USA |
 |
iCAD
ICAD
|
-49 K | - | - | $ 102 M | USA |
 |
Change Healthcare
CHNG
|
234 M | - | - | $ 9.03 B | USA |
 |
MTBC
MTBC
|
-298 K | - | -0.58 % | $ 51.7 M | USA |
 |
Evolent Health
EVH
|
15.6 M | $ 4.13 | -0.72 % | $ 387 M | USA |
 |
HealthStream
HSTM
|
-318 K | $ 23.83 | -0.75 % | $ 724 M | USA |
 |
Progyny
PGNY
|
1.87 M | $ 25.51 | -0.23 % | $ 2.19 B | USA |
 |
Phreesia
PHR
|
1.85 M | $ 16.81 | 0.18 % | $ 917 M | USA |
 |
OptimizeRx Corporation
OPRX
|
1.45 M | $ 12.76 | 0.16 % | $ 219 M | USA |
 |
Akerna Corp.
KERN
|
446 K | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
55.5 M | $ 92.45 | -0.26 % | $ 7.91 B | USA |
 |
American Well Corporation
AMWL
|
11.8 M | $ 4.59 | 0.66 % | $ 68.8 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
13.2 M | - | -10.39 % | $ 886 M | USA |
 |
GoodRx Holdings
GDRX
|
-2.66 M | $ 2.77 | 0.73 % | $ 1.07 B | USA |
 |
Omnicell
OMCL
|
-270 K | $ 45.78 | 0.46 % | $ 2.11 B | USA |
 |
1Life Healthcare
ONEM
|
-13.8 M | - | - | $ 3.37 B | USA |
 |
So-Young International
SY
|
12 M | $ 2.8 | -3.45 % | $ 222 M |  China |
 |
Schrödinger
SDGR
|
17.9 M | $ 18.38 | -2.29 % | $ 1.34 B | USA |
 |
NantHealth
NH
|
-2.65 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
3.52 M | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
20.6 M | - | -0.02 % | $ 7.21 B | USA |
 |
Zhongchao
ZCMD
|
34 K | $ 0.53 | -1.34 % | $ 2.76 M | China |
 |
Streamline Health Solutions
STRM
|
-2 K | - | - | $ 21.4 M | USA |
 |
10x Genomics
TXG
|
33 K | $ 16.69 | 1.15 % | $ 1.96 B | USA |
 |
Teladoc Health
TDOC
|
23.8 M | $ 7.25 | 0.55 % | $ 1.24 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
1.06 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
159 M | $ 223.15 | -0.49 % | $ 35.8 B | USA |
 |
SCWorx Corp.
WORX
|
279 K | $ 0.2 | -1.6 % | $ 292 K | USA |